Drugs Made In America Acquisition DMIIU
NASDAQ DMIIU
$10.23 +0.00 (+0.00%)
At close: Nov 3, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMIIU) Total Current Liabilities (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMIIU) posted Total Current Liabilities of $644,574 for Q2 2026.

Analysis

Drugs Made In America Acquisition (DMIIU) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition's Total Current Liabilities came in at $300,864, up 18.1% from FY2024.

  • In prior years, Drugs Made In America Acquisition's Total Current Liabilities was $254,783 in FY2024.
  • Quarterly Total Current Liabilities has run from a low of $254,783 in Q4 2024 to a high of $677,345 in Q3 2025 over five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 644,574.00
Dec 31, 2025 300,864.00
Sep 30, 2025 677,345.00
Dec 31, 2024 254,783.00
API Access

Drugs Made In America Acquisition Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=DMIIU&period=max&api_key=YOUR_API_KEY